Dapiglutide-impurities | Pharmaffiliates

Dapiglutide

Dapiglutide is under investigation in clinical trial NCT05788601. Dapiglutide for the Treatment of Obesity. Reference standards of Dapiglutide API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

stdClass Object
(
    [pname] => Dapiglutide - API Standards
    [catalogue_number] => PA PEP 001160
    [category_ids] => ,114,
    [chemical_name] => 
    [weight] => 4166.79
    [form] => C192H302N46O57
    [cas] => 2296814-85-0
    [pslug] => 2296814-85-0-dapiglutide-api-standards-papep001160
    [latest_product] => 0
    [linkproducts] => 0
    [offers_id] => 
    [offers_name] => 
    [offers_status] => 
    [offers_start_date] => 
    [offers_end_date] => 
    [pageview] => 
    [offers_slug] => 
    [offers_product_id] => 
    [offers_product_code] => 
    [offers_master_id] => 
    [offer_percentage] => 
    [offers_product_main_cat] => 
)
PA PEP 001160

Dapiglutide - API Standards


  • Catalogue No.:PA PEP 001160

  • CAS :

    2296814-85-0

  • Molecular Formula : C192H302N46O57

  • Molecular Weight : 4166.79